Cargando…
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes
The potential anticancer effects of statins—a widely used class of cholesterol lowering drugs—has generated significant interest, as has the use of epigenetic modifying drugs such as HDAC and DNMT inhibitors. We set out to investigate the effect of statin drugs on epigenetic modifications in multipl...
Autores principales: | Bridgeman, Stephanie, Northrop, Wendy, Ellison, Gaewyn, Sabapathy, Thiru, Melton, Phillip E., Newsholme, Philip, Mamotte, Cyril D. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521159/ https://www.ncbi.nlm.nih.gov/pubmed/30974899 http://dx.doi.org/10.3390/cancers11040516 |
Ejemplares similares
-
The HDAC Inhibitor Butyrate Impairs β Cell Function and Activates the Disallowed Gene Hexokinase I
por: Bridgeman, Stephanie, et al.
Publicado: (2021) -
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling
por: Bridgeman, Stephanie, et al.
Publicado: (2022) -
Revisiting the Interaction of Melittin with Phospholipid Bilayers: The Effects of Concentration and Ionic Strength
por: Sabapathy, Thiru, et al.
Publicado: (2020) -
Statins impact on epigenetics of tumor cells
por: Kulaksiz, Murtaza, et al.
Publicado: (2012) -
Do Not Treat Children with Statins
por: Diamond, David M., et al.
Publicado: (2019)